Dec 2 (Reuters) - Novartis AG NOVN.S:
PTC THERAPEUTICS ENTERS INTO A GLOBAL LICENSE AND COLLABORATION AGREEMENT WITH NOVARTIS FOR PTC518 HUNTINGTON'S DISEASE PROGRAM
PTC THERAPEUTICS INC - TO RECEIVE $1 BILLION IN CASH AT CLOSING
PTC THERAPEUTICS INC - ELIGIBLE TO RECEIVE UP TO $1.9 BILLION IN MILESTONES
PTC THERAPEUTICS INC - NOVARTIS TO ASSUME GLOBAL DEVELOPMENT AND COMMERCIAL RESPONSIBILITIES
Source text: ID:nPn3HzZL0a
Further company coverage: NOVN.S
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.